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Letters to the EditorTo avoid migration of the Edwards
valve, the prosthesis can be overin-
flated or its shape can be manufac-
tured according to this structure.
Although the aortic valve area was
found to be 2.1  0.5 cm2, the 26-
mm valve was replaced in 65% of
the patients, demonstrating that the
valve can be widened by 35%. This
additional widening will diminish par-
avalvular regurgitation.
There could be disagreement con-
cerning additional widening, be-
cause some investigators favor the
theory that this widening will oblit-
erate the coronary orifices, resulting
in complications. However, Kalav-
rouziotis and colleagues3 applied
a 23-mm Edwards Sapien to a small
annulus and had a success rate of
97%. We believe that additional
widening using balloon dilation
will further lower the incidence of
regurgitation.
Although Sherif and colleagues4
showed that 1 reason for paravalvular
regurgitation was the angle between
the preoperative septum and the left
ventricular outflow tract, we do not
believe this is possible because, after
the operation, the flow, pressure, wall
thickness, and angle will change.
Also, this change in angle is not the
precise reason for paravalvular
regurgitation.
Blanke and colleagues5 compared
the hinge-to-hinge and virtual-ring
methods for transcatheter aortic valve
implantation and found no differ-
ences. We think both methods are in-
sufficient, because the prosthesis is
located over a thick leaflet and not
the annulus, and this necessitates a cal-
culation of the leaflet thickness and
the amount of opening.
In these studies, the hinge-to-hinge
and virtual-ring calculations do not
correlate with the fact that the valve
is seated over the leaflet. To what
point should the leaflet be opened
and at what point should the leaflet
thickness be calculated? It has been
shown that leaflet opening is not
enough (although the diameter is 32The Journalmm); thus, we recommend that valve
dilation by conserving the coronary
orifices will help prevent paravalvu-
lar regurgitation. We have concluded
that transvalvular regurgitation is
the consequence of asymmetry.
The point to which it needs to be di-
lated can be calculated using elliptic
balloons. The noncoronary cusp, at
which most calcifications are located,
can be dilated. Today, we have deter-
mined that there are enough findings
to indicate that the actual valves can
be dilated. The transcatheter aortic
valve implantation team leader
should be a cardiac surgeon experi-
enced in aortic valve surgery.
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We thank Dr Bozok and colleagues
for their useful comments and sugges-
tions to reduce paravalvular leak after
transapical aortic valve implantation.
In our study based on data from the
Italian Registry of Trans-Apical Aortic
Valve Implantation,1 the incidence of
paravalvular leak (trivial and mild)
was 38%, and this is consistent with
the incidence reported by other series.2
Reducing the incidence of paravalvu-
lar leak is of outmost importance to
improve patient outcomes. In fact, it
has been demonstrated that the pres-
ence of paravalvular aortic regurgita-
tion after transcatheter aortic valve
implantation is associated with an in-
creased rate of late mortality and that
the effect of aortic regurgitation on
mortality is proportional to the severity
of the regurgitation. Furthermore, even
mild aortic regurgitation is associated
with an increased rate of late deaths.3
Overexpansion of the Sapien valve
after deployment might be useful, but
it is controversial and should be per-
formed carefully. Many complica-
tions can occur after this procedure,
including not only coronary ostia oc-
clusion, but also rupture of the aortic
annulus and injury to the prosthetic
valve leaflets. Furthermore, in our ex-
perience, overexpansion of the Sapien
valve after deployment is often asso-
ciated with a small (or none)
reduction of the degree of paravalvu-
lar regurgitation. We agree with Dr
Bozok that asymmetry of the calcium
distribution over the leaflets and an-
nulus is a major determinant of para-
valvular regurgitation; however, other
important causes should be also
carefully considered such as correct
sizing and correct positioning.
Correct sizing needs an experienced
multidisciplinary and multimodalry c Volume 144, Number 2 521
Letters to the Editor(2-dimensional and 3-dimensional
transthoracic and transesophageal
echocardiography, multidetector com-
puterized tomography scan) evalua-
tion of the annulus dimensions and
shape (the annulus is often oval and
not circular) and a semiquantitative
evaluation of the amount of calcium
on the annulus and the leaflets. In
fact, for the intermediate annulus di-
ameters, the choice of a larger or
a smaller valve depends on the
amount of calcium. A larger valve in
an extremely calcified annulus can
cause rupture of the aortoventricular
junction with consequent massive
hemorrhage. However, a small valve
in a poorly calcified annulus can lead
to paravalvular regurgitation or, more
dramatically, device embolization.
Correct positioning requires experi-
ence and a strong synergic coopera-
tion among all the components of the
transcatheter aortic valve implantation
team. The definition of valve malposi-
tioning includes not only a valve posi-
tioned too high or too low, but also
a problem of alignment between the
valve and longitudinal axis of the aor-
tic annulus. An asymmetric ‘‘diago-
nal’’ landing of the prosthesis on the
annulus might lead to paravalvular re-
gurgitation and to an abnormal
stress on the leaflets with a greater po-
tential risk of early structural
dysfunction.
In conclusion, we believe that even
if valve overexpansion might be care-
fully considered to reduce paravalvu-
lar leak, the transcatheter aortic
valve implantation results can be in-
creased mainly by improving patient
selection, annulus sizing, valve posi-
tioning, and cooperation among mem-
bers, as well as the experience of the
transcatheter aortic valve implanta-
tion team.
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IMPLANTATION TO YOUNGER,
LOWER-RISK PATIENTS?
To the Editor:
We read with interest the 2-year
follow-up results of 227 patients with
amean age of 81 years who underwent
transcatheter aortic valve implantation
(TAVI) by Bleiziffer and colleagues.1
The authors have concluded that
there was ‘‘overall low morbidity at
2 years’’ and that the findings justify
offering TAVI to lower-risk octoge-
narians and high-risk younger pa-
tients. We do not concur with their
conclusions.
The 30-day mortality in the series
reported by Bleiziffer and colleagues1
was 12% with a periprocedural
cerebral vascular accident rate of
7%, a myocardial infarction rate of
4%, an acute kidney injury rate
of 10%, and an overall vascular com-
plication rate of 23% (8% of which
were major vascular events). Further-
more, 50% of patients had mild to
severe central and paravalvular regur-
gitation. The rate of pacemaker im-
plantation is not given; however, in
other TAVI series and in our hands it
is approximately 20%.
Before the introduction of TAVI in
the United Kingdom, the sixth na-
tional adult cardiac surgical databaseardiovascular Surgery c August 2012report, which was published in
2008,2 showed an overall mortality
of 2.8% for all isolated aortic valve
replacements and this figure was
5.5% to 5.8% in octogenarians.
We would like to share 2 other con-
cerns with the readers: The diagnosis
of porcelain aorta is made in nearly
10% of TAVI populations. This figure
is widely different from and higher
than what the surgical community
has experienced with aortic valve sur-
gery. Is it perhaps an over diagnosis?
Furthermore, the effect of balloon
dilatation on the integrity of the TAVI
prosthesis warrants attention. Insertion
of the Sapien valve (Edwards Life-
sciences, Irvine, Calif) requires bal-
loon expansion, and the practice of
further ballooning of Sapien or Core-
Valve prostheses (Medtronic, Inc,Min-
neapolis, Minn) to reduce paravalvular
leak may affect the integrity and thus
durability of these valves.
We appreciate that the TAVI cohort
probably has a higher EuroSCORE or
Society of Thoracic Surgeons score.
We are a main TAVI center in the
United Kingdom, with significant sur-
gical input and driving force, but we
believe that unless the results and out-
comes can match surgery to some ex-
tent, TAVI should not be expanded to
younger or lower-risk patients.
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